Results 261 to 270 of about 87,487 (309)

A Comprehensive Review of the Clinical Evidence on the Efficacy, Effectiveness, and Safety of Silodosin for the Treatment of Benign Prostatic Hyperplasia. [PDF]

Cureus
Akhtar OS, Singh V, Bhojani KA, Dharmadhikari S, Bhargave C, Mane A, Mehta S.   +6 more
europepmc   +1 more source

The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them? [PDF]

Maedica (Bucur)
Balacescu S, Geavlete B, Ungureanu C, Ene C, Ene CD, Bulai C, Mares C, Punga A, Militaru A, Geavlete P.   +9 more
europepmc   +1 more source

Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990-2021. [PDF]

BMC Public Health
Safiri S, Şahin F, Aletaha R, Sullman MJM, Shekarriz-Foumani R, Kolahi AA.   +5 more
europepmc   +1 more source

Chronic Periodontitis as a Risk Factor for Benign Prostatic Hyperplasia: A Cohort Study. [PDF]

J Clin Med
Kwon MJ, Kang HS, Choi HG, Kim JH, Yoo DM, Lee NE, Han KM, Bang WJ.   +7 more
europepmc   +1 more source

Tracking and analysis of benign prostatic hyperplasia and prostate cancer burden globally: 1990-2021 epidemiological trends. [PDF]

Transl Androl Urol
Mo Q, Wang F, Liang H, Li Y, Qin M, Cheng J.   +5 more
europepmc   +1 more source

Predicting early clinical success of prostate artery embolization using MRI perfusion in benign prostatic hyperplasia. [PDF]

CVIR Endovasc
Sammoud S, De Oliviera F, Kammoun T, Loukil H, Jelloun GTB, Ghabri S, Nabi W, Droupy S, Gres P, Beregi JP, Frandon J.   +10 more
europepmc   +1 more source

TNF-α modulates cell proliferation via SOX4/TGF-β/Smad signaling in benign prostatic hyperplasia. [PDF]

Cell Death Dis
Li J, Chen B, Huang Y, Liao X, You J, Chen Z, Ning S, Reda A, Zhao J, Ran B, Bai J, Zhu M, Wang Y, Chen H, Wei Q, Cao D, Liu L.   +16 more
europepmc   +1 more source

Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives. [PDF]

Diseases
Kaltsas A, Giannakas T, Stavropoulos M, Kratiras Z, Chrisofos M.   +4 more
europepmc   +1 more source

Protective effect of the hydroethanolic extract of camelthorn (Alhagi maurorum) on benign prostatic hyperplasia induced by testosterone in rats. [PDF]

BMC Complement Med Ther
Hoseinpour F, Hashemnia M, Cheraghi H, Salari Asl MM, Zare F, Zanjani IA.   +5 more
europepmc   +1 more source

U-Net benign prostatic hyperplasia-trained deep learning model for prostate ultrasound image segmentation in prostate cancer. [PDF]

Quant Imaging Med Surg
Jiao P, Wang Z, Chen Z, Weng X, Liu X, Yang R, Zheng Q.   +6 more
europepmc   +1 more source